Clinical trial
Retrospective Analysis of Endostatin Genotype in Prostate Cancer Patients to Assess the Association of a Single Nucleotide Polymorphism (D104N) in Endostatin and Prostate Cancer
NCT00900185 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retrospective Analysis of Endostatin Genotype in Prostate Cancer Patients to Assess the Association of a Single Nucleotide Polymorphism (D104N) in Endostatin and Prostate Cancer
- Lead sponsor
- National Cancer Institute (NCI)
- Phase
- Observational
- Overall status
- Completed
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- 750 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer